Single-question low back pain severity assessment accurate

Single-question low back pain severity assessment accurate
Patient-reported chronic low-back pain severity, based on answering a single question, provides an accurate indicator of patient-reported health status, according to a study published in the February issue of the Journal of Spinal Disorders & Techniques.

(HealthDay)—Patient-reported chronic low-back pain (CLBP) severity, based on answering a single question, provides an accurate indicator of patient-reported health status, according to a study published in the February issue of the Journal of Spinal Disorders & Techniques.

Alesia B. Sadosky, Ph.D., M.P.H., M.B.A., from Global Health Economics and Outcomes Research at Pfizer Inc. in New York City, and colleagues analyzed data from the 2009 Adelphi Disease Specific Programme, in which reported the severity of their CLBP condition by answering a single question: "Please rate how your CLBP condition is today." Patient reported severity (mild, moderate, or severe) was assessed with respect to scores on standard patient self-report measures of and function.

The researchers found that, of the 1,363 survey respondents (49 percent male; mean age, 54.8 years; 52 percent employed at least part time), 28.6, 53.3, and 18.2 percent, respectively, reported mild, moderate, and severe CLBP. As the severity of CLBP increased, there were significant differences observed in increased pain, pain interference with function, and CLBP-linked impairment while working, mainly due to presenteeism. There were higher costs related to lost work productivity resulting from increased work impairment, with estimated annual lost productivity costs of $7,080 per patient for mild CLBP, $16,616 for moderate CLBP, and $25,032 for CLBP. CLBP severity was inversely associated with patient satisfaction with pain-related medication.

"The association between patient-reported CLBP severity and other patient-reported outcomes demonstrates that in the clinical setting, patient-reported CLBP severity provides an accurate and suitable indicator of patient-reported ," the authors write.

Several authors are employed by or disclosed financial ties to Pfizer and Adelphi. The study was supported by Pfizer.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Guidelines presented for diagnosing focal liver lesions

6 hours ago

(HealthDay)—Focal liver lesions (FLLs) are mostly benign, and can be diagnosed based on knowledge of their presentation, associated clinical and laboratory features, and natural history, according to clinical ...

Factors tied to neck, back pain improvement identified

10 hours ago

(HealthDay)—Observational registry-based research can inform patients and physicians about prognosis for subacute or chronic neck or low back pain, according to a study published in the Aug. 1 issue of ...

User comments